22,135,656
Vote Records
28,570
Companies
12,092
Funds
3,981
Managers

Home › Companies › IMMUNOCORE HOLDINGS PLC › 2024-2025

IMMUNOCORE HOLDINGS PLC 2024-2025 Proxy Voting Records

Download data (CSV): ballot items · votes by manager · column guide.

Compiled from SEC Form N-PX filings and IMMUNOCORE HOLDINGS PLC’s Form 8-K, filed May 15, 2025 (Item 5.07 on EDGAR). Page generated November 20, 2026.

  • 13Reported items
  • 118Asset managers, any item
  • 974Fund votes
  • May 15, 2025Meeting date

Results at a glance

Meeting of May 15, 2025: 12 items on IMMUNOCORE HOLDINGS PLC’s Form 8-K, filed May 15, 2025: 12 passed (calculated).

Dissent

No notable dissent.

Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Activist investors: Tang Capital (13F, 5.6%, as of September 30, 2026) · Caligan Partners (13F, 3.2%, as of September 30, 2026)

Explore IMMUNOCORE HOLDINGS PLC in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by IMMUNOCORE HOLDINGS PLC

These tallies are IMMUNOCORE HOLDINGS PLC’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 15, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

IMMUNOCORE HOLDINGS PLC — official shareholder meeting results, meeting held May 15, 2025
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
To re-appoint as a director of the Company Ranjeev Krishana. 32,271,306472,0253,089 ---- 99%Passed (calculated)—
To re-appoint as a director of the Company Professor Sir Peter Ratcliffe. 30,325,6732,417,6583,089 ---- 93%Passed (calculated)—
To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement. 27,835,0464,908,0153,359 ---- 85%Passed (calculated)—
To ratify the appointment of Deloitte LLP, a limited liability partnership organized under the laws of England, as the Company's U.S. independent registered public accounting firm for the year ending December 31, 2025. 32,742,1561,5282,736 ---- 99.9%Passed (calculated)—
To re-appoint Deloitte LLP, a limited liability partnership organized under the laws of England, as the Company's U.K. statutory auditors, to hold office until the conclusion of the next annual general meeting of shareholders 32,742,1751,4992,746 ---- 99.9%Passed (calculated)—
To authorize the audit committee to determine the U.K. statutory auditors' remuneration for the year ending December 31, 2025. 32,741,5792,1052,736 ---- 99.9%Passed (calculated)—
To receive and adopt the U.K. statutory annual accounts and reports for the year ended December 31, 2024 (the "2024 U.K. 32,741,6471,4963,277 ---- 99.9%Passed (calculated)—
To approve the directors' remuneration report for the year ended December 31, 2024, which is set forth as Annex A to the Proxy Statement and on pages 22 to 49 of the 2024 U.K. Annual Report (excluding the directors' remunerat 27,889,9304,853,1063,384 ---- 85%Passed (calculated)—
To approve the directors' remuneration policy, which is set forth on pages A-5 to A-15 of Annex A to the Proxy Statement. 27,915,1274,827,9053,388 ---- 85%Passed (calculated)—
To authorize the Company to make political donations/incur political expenditure. 32,687,7655,74152,914 ---- 99.9%Passed (calculated)—
To authorize the directors of the Company to allot shares in the Company or to grant rights to subscribe for or to convert any security into shares in the Company up to an aggregate nominal amount of £150,000 for a period ex 27,948,8844,793,1774,359 ---- 85%Passed (calculated)—
Special Resolution 13 : To empower the directors of the Company to allot equity securities for cash pursuant to the general authority conferred on them by resolution 12. 27,949,5634,792,7944,063 ---- 85%Passed (calculated)—

Source: IMMUNOCORE HOLDINGS PLC, Form 8-K, filed with the SEC on May 15, 2025 — read the filing on EDGAR.

How asset managers voted at the IMMUNOCORE HOLDINGS PLC 2024-2025 meeting

118 asset managers disclosed a vote on at least one IMMUNOCORE HOLDINGS PLC item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of IMMUNOCORE HOLDINGS PLC’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

To re-appoint as a director of the Company Professor Sir Peter Ratcliffe.

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 2 wordings of this item as funds reported it.

93% Majority: yes · of votes cast

FOR 93%
FOR: 30,325,673AGAINST: 2,417,658
Details: description as filed, official tally, votes by 30 asset managers

Description as filed by funds: To re-appoint as a director Professor Sir Peter Ratcliffe, who retires in accordance with the articles of association.

IMMUNOCORE HOLDINGS PLC’s own tally for this item (“Resolution 3 : To re-appoint as a director of the Company Professor Sir Peter Ratcliffe.”): 30,325,673 for, 2,417,658 against, per its Form 8-K filed May 15, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 93% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 30 asset managers below reported 15,150,739 for, 739,832 against, 2,525 abstained.

FOR
FOR: 15,150,739AGAINST: 739,832ABSTAIN: 2,525
Largest asset managers voting on “To re-appoint as a director Professor Sir Peter Ratcliffe, who retires in accordance with the articles of asso” at IMMUNOCORE HOLDINGS PLC, 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard6,114,5940 00For
T. Rowe Price4,690,9860 00For
Fidelity3,213,8450 00For
PRIMECAP Odyssey Funds748,4300 00For
MFS0402,400 00Against
Principal0201,762 00Against
New York Life93,2730 00For
Pacific Life28,45252,343 00Mixed
Northwestern Mutual68,5590 00For
Hartford68,2210 00For
BlackRock41,2710 00For
STEWARD FUNDS, INC.037,465 00Against
John Hancock29,0980 00For
Nationwide27,9300 00For
Tema ETF Trust15,4280 00For
PRINCIPAL VARIABLE CONTRACTS FUNDS INC010,567 00Against
OLD WESTBURY FUNDS INC09,366 00Against
Goldman Sachs07,524 00Against
Blackstone Alternative Investment Funds06,500 00Against
ETF Series Solutions04,770 00Against
State Street4,2140 00For
Guardian Variable Products Trust3,8030 00For
ALPS ETF Trust03,590 00Against
AuguStar00 2,5250Abstain
Equitable1,8080 00For

Showing the 25 largest of 30 asset managers. All 30 are in the interactive database (link above).

To re-appoint as a director of the Company Ranjeev Krishana.

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 2 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%
FOR: 32,271,306AGAINST: 472,025
Details: description as filed, official tally, votes by 30 asset managers

Description as filed by funds: To re-appoint as a director Ranjeev Krishana, who retires in accordance with the articles of association.

IMMUNOCORE HOLDINGS PLC’s own tally for this item (“Resolution 2 : To re-appoint as a director of the Company Ranjeev Krishana.”): 32,271,306 for, 472,025 against, per its Form 8-K filed May 15, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 30 asset managers below reported 15,890,571 for, 2,525 abstained.

FOR
FOR: 15,890,571ABSTAIN: 2,525
Largest asset managers voting on “To re-appoint as a director Ranjeev Krishana, who retires in accordance with the articles of association.” at IMMUNOCORE HOLDINGS PLC, 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard6,114,5940 00For
T. Rowe Price4,690,9860 00For
Fidelity3,213,8450 00For
PRIMECAP Odyssey Funds748,4300 00For
MFS402,4000 00For
Principal201,7620 00For
New York Life93,2730 00For
Pacific Life80,7950 00For
Northwestern Mutual68,5590 00For
Hartford68,2210 00For
BlackRock41,2710 00For
STEWARD FUNDS, INC.37,4650 00For
John Hancock29,0980 00For
Nationwide27,9300 00For
Tema ETF Trust15,4280 00For
PRINCIPAL VARIABLE CONTRACTS FUNDS INC10,5670 00For
OLD WESTBURY FUNDS INC9,3660 00For
Goldman Sachs7,5240 00For
Blackstone Alternative Investment Funds6,5000 00For
ETF Series Solutions4,7700 00For
State Street4,2140 00For
Guardian Variable Products Trust3,8030 00For
ALPS ETF Trust3,5900 00For
AuguStar00 2,5250Abstain
Equitable1,8080 00For

Showing the 25 largest of 30 asset managers. All 30 are in the interactive database (link above).

To re-appoint as a director Roy S. Herbst, M.D., Ph.D., who retires in accordance with the articles of association.

No official matchDIRECTOR ELECTIONS

Combines 2 wordings of this item as funds reported it.

36% of fund votes cast · no official result

FORAGAINST
Details: votes by 30 asset managers

The 30 asset managers below reported 5,761,889 for, 10,128,682 against, 2,525 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 5,761,889AGAINST: 10,128,682ABSTAIN: 2,525
Largest asset managers voting on “To re-appoint as a director Roy S. Herbst, M.D., Ph.D., who retires in accordance with the articles of associa” at IMMUNOCORE HOLDINGS PLC, 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard1,756,3904,358,204 00Mixed
T. Rowe Price3,188,2311,502,755 00Mixed
Fidelity03,213,845 00Against
PRIMECAP Odyssey Funds748,4300 00For
MFS0402,400 00Against
Principal0201,762 00Against
New York Life093,273 00Against
Pacific Life080,795 00Against
Northwestern Mutual68,5590 00For
Hartford068,221 00Against
BlackRock041,271 00Against
STEWARD FUNDS, INC.037,465 00Against
John Hancock17628,922 00Against
Nationwide027,930 00Against
Tema ETF Trust015,428 00Against
PRINCIPAL VARIABLE CONTRACTS FUNDS INC010,567 00Against
OLD WESTBURY FUNDS INC09,366 00Against
Goldman Sachs07,524 00Against
Blackstone Alternative Investment Funds06,500 00Against
ETF Series Solutions04,770 00Against
State Street04,214 00Against
Guardian Variable Products Trust03,803 00Against
ALPS ETF Trust03,590 00Against
AuguStar00 2,5250Abstain
Equitable01,808 00Against

Showing the 25 largest of 30 asset managers. All 30 are in the interactive database (link above).

To authorize the directors of the Company to allot shares in the Company or to grant rights to subscribe for or to…

Calculated outcomeFund totals may overlapCAPITAL STRUCTUREPassed (calculated)

Combines 4 wordings of this item as funds reported it.

85% Majority: yes · of votes cast

FOR 85%AGAINST
FOR: 27,948,884AGAINST: 4,793,177
Details: description as filed, official tally, votes by 31 asset managers

Description as filed by funds: To authorize the directors to allot shares or to grant rights to subscribe for or convert any security into shares up to an aggregate nominal amount of pounds150,000.

IMMUNOCORE HOLDINGS PLC’s own tally for this item (“Resolution 12 : To authorize the directors of the Company to allot shares in the Company or to grant rights to subscribe for or to convert any security into shares in the Company up to an aggregate nominal amount of £150”): 27,948,884 for, 4,793,177 against, per its Form 8-K filed May 15, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 85% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 30 asset managers voting on “To authorize the directors to allot shares or to grant rights to subscribe for or convert any security into sh” at IMMUNOCORE HOLDINGS PLC, 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard6,114,5940 00For
T. Rowe Price3,188,2311,502,755 00Mixed
Fidelity3,178,32535,520 00For
PRIMECAP Odyssey Funds748,4300 00For
MFS402,4000 00For
Principal0201,762 00Against
New York Life093,273 00Against
Pacific Life80,7950 00For
Northwestern Mutual68,5590 00For
Hartford68,2210 00For
BlackRock41,2710 00For
STEWARD FUNDS, INC.037,465 00Against
John Hancock17628,922 00Against
Nationwide27,9300 00For
Tema ETF Trust15,4280 00For
PRINCIPAL VARIABLE CONTRACTS FUNDS INC010,567 00Against
OLD WESTBURY FUNDS INC09,366 00Against
Goldman Sachs07,524 00Against
Blackstone Alternative Investment Funds06,500 00Against
ETF Series Solutions04,770 00Against
State Street04,214 00Against
Guardian Variable Products Trust3,8030 00For
ALPS ETF Trust03,590 00Against
AuguStar02,525 00Against
Equitable01,808 00Against

Fund voting reports, all 30 managers: 13,938,990 for, 1,954,106 against. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 1 asset manager voting on “To authorize the directors to allot shares or to grant rights to subscribe for or convert any security into sh” at IMMUNOCORE HOLDINGS PLC, 2024-2025
Asset managerForAgainst AbstainWithheldVote
Kynam Capital Management, LP00 0834,479Withhold

Institutional-manager reports, all 1 managers: 834,479 withheld.

Special Resolution 13 : To empower the directors of the Company to allot equity securities for cash pursuant to the…

Calculated outcomeCAPITAL STRUCTUREPassed (calculated)

85% Majority: yes · of votes cast

FOR 85%AGAINST
FOR: 27,949,563AGAINST: 4,792,794
Details: description as filed, official tally, votes by 30 asset managers

Description as filed by funds: To empower the directors to allot equity securities for cash pursuant to the authorization in resolution 12 as if U.K. statutory pre-emption rights did not apply.

IMMUNOCORE HOLDINGS PLC’s own tally for this item (“Special Resolution Resolution 13 : To empower the directors of the Company to allot equity securities for cash pursuant to the general authority conferred on them by resolution 12.”): 27,949,563 for, 4,792,794 against, per its Form 8-K filed May 15, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 85% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 30 asset managers below reported 13,938,990 for, 1,954,106 against.

FOR
FOR: 13,938,990AGAINST: 1,954,106
Largest asset managers voting on “To empower the directors to allot equity securities for cash pursuant to the authorization in resolution 12 as” at IMMUNOCORE HOLDINGS PLC, 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard6,114,5940 00For
T. Rowe Price3,188,2311,502,755 00Mixed
Fidelity3,178,32535,520 00For
PRIMECAP Odyssey Funds748,4300 00For
MFS402,4000 00For
Principal0201,762 00Against
New York Life093,273 00Against
Pacific Life80,7950 00For
Northwestern Mutual68,5590 00For
Hartford68,2210 00For
BlackRock41,2710 00For
STEWARD FUNDS, INC.037,465 00Against
John Hancock17628,922 00Against
Nationwide27,9300 00For
Tema ETF Trust15,4280 00For
PRINCIPAL VARIABLE CONTRACTS FUNDS INC010,567 00Against
OLD WESTBURY FUNDS INC09,366 00Against
Goldman Sachs07,524 00Against
Blackstone Alternative Investment Funds06,500 00Against
ETF Series Solutions04,770 00Against
State Street04,214 00Against
Guardian Variable Products Trust3,8030 00For
ALPS ETF Trust03,590 00Against
AuguStar02,525 00Against
Equitable01,808 00Against

Showing the 25 largest of 30 asset managers. All 30 are in the interactive database (link above).

To receive and adopt the U.K. statutory annual accounts and reports for the year ended December 31, 2024 (the "2024 U.K.

Calculated outcomeCORPORATE GOVERNANCEPassed (calculated)

Combines 2 wordings of this item as funds reported it.

99.9% Majority: yes · of votes cast

FOR 99.9%
FOR: 32,741,647AGAINST: 1,496
Details: description as filed, official tally, votes by 30 asset managers

Description as filed by funds: To receive and adopt the U.K. statutory annual accounts and reports for the year ended 31 December 2024.

IMMUNOCORE HOLDINGS PLC’s own tally for this item (“Resolution 8 : To receive and adopt the U.K. statutory annual accounts and reports for the year ended December 31, 2024 (the "2024 U.K.”): 32,741,647 for, 1,496 against, per its Form 8-K filed May 15, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 30 asset managers below reported 15,890,571 for, 2,525 abstained.

FOR
FOR: 15,890,571ABSTAIN: 2,525
Largest asset managers voting on “To receive and adopt the U.K. statutory annual accounts and reports for the year ended 31 December 2024.” at IMMUNOCORE HOLDINGS PLC, 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard6,114,5940 00For
T. Rowe Price4,690,9860 00For
Fidelity3,213,8450 00For
PRIMECAP Odyssey Funds748,4300 00For
MFS402,4000 00For
Principal201,7620 00For
New York Life93,2730 00For
Pacific Life80,7950 00For
Northwestern Mutual68,5590 00For
Hartford68,2210 00For
BlackRock41,2710 00For
STEWARD FUNDS, INC.37,4650 00For
John Hancock29,0980 00For
Nationwide27,9300 00For
Tema ETF Trust15,4280 00For
PRINCIPAL VARIABLE CONTRACTS FUNDS INC10,5670 00For
OLD WESTBURY FUNDS INC9,3660 00For
Goldman Sachs7,5240 00For
Blackstone Alternative Investment Funds6,5000 00For
ETF Series Solutions4,7700 00For
State Street4,2140 00For
Guardian Variable Products Trust3,8030 00For
ALPS ETF Trust3,5900 00For
AuguStar00 2,5250Abstain
Equitable1,8080 00For

Showing the 25 largest of 30 asset managers. All 30 are in the interactive database (link above).

To authorize the Company to make political donations/incur political expenditure.

Calculated outcomeOTHER SOCIAL ISSUESPassed (calculated)

Combines 2 wordings of this item as funds reported it.

99.9% Majority: yes · of votes cast

FOR 99.9%
FOR: 32,687,765AGAINST: 5,741
Details: official tally, votes by 30 asset managers

IMMUNOCORE HOLDINGS PLC’s own tally for this item (“Resolution 11 : To authorize the Company to make political donations/incur political expenditure.”): 32,687,765 for, 5,741 against, per its Form 8-K filed May 15, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 30 asset managers below reported 15,890,571 for, 2,525 abstained.

FOR
FOR: 15,890,571ABSTAIN: 2,525
Largest asset managers voting on “To authorize the Company to make political donations/incur political expenditure.” at IMMUNOCORE HOLDINGS PLC, 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard6,114,5940 00For
T. Rowe Price4,690,9860 00For
Fidelity3,213,8450 00For
PRIMECAP Odyssey Funds748,4300 00For
MFS402,4000 00For
Principal201,7620 00For
New York Life93,2730 00For
Pacific Life80,7950 00For
Northwestern Mutual68,5590 00For
Hartford68,2210 00For
BlackRock41,2710 00For
STEWARD FUNDS, INC.37,4650 00For
John Hancock29,0980 00For
Nationwide27,9300 00For
Tema ETF Trust15,4280 00For
PRINCIPAL VARIABLE CONTRACTS FUNDS INC10,5670 00For
OLD WESTBURY FUNDS INC9,3660 00For
Goldman Sachs7,5240 00For
Blackstone Alternative Investment Funds6,5000 00For
ETF Series Solutions4,7700 00For
State Street4,2140 00For
Guardian Variable Products Trust3,8030 00For
ALPS ETF Trust3,5900 00For
AuguStar00 2,5250Abstain
Equitable1,8080 00For

Showing the 25 largest of 30 asset managers. All 30 are in the interactive database (link above).

To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy…

Calculated outcomeFund totals may overlapSECTION 14A SAY-ON-PAY VOTESPassed (calculated)

Combines 8 wordings of this item as funds reported it.

85% Majority: yes · of votes cast

FOR 85%AGAINST
FOR: 27,835,046AGAINST: 4,908,015

Prior year: 98.1% for (May 23, 2024 meeting) ▼ 13.1 pts

Details: description as filed, official tally, votes by 117 asset managers

Description as filed by funds: To approve, on advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement.

IMMUNOCORE HOLDINGS PLC’s own tally for this item (“Resolution 4: To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement.”): 27,835,046 for, 4,908,015 against, per its Form 8-K filed May 15, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 85% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 30 asset managers voting on “To approve, on advisory basis, the compensation of the Company's named executive officers, as disclosed in the” at IMMUNOCORE HOLDINGS PLC, 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard6,114,5940 00For
T. Rowe Price3,188,2311,502,755 00Mixed
Fidelity3,178,32535,520 00For
PRIMECAP Odyssey Funds748,4300 00For
MFS402,4000 00For
Principal0201,762 00Against
New York Life093,273 00Against
Pacific Life80,7950 00For
Northwestern Mutual68,5590 00For
Hartford68,2210 00For
BlackRock041,271 00Against
STEWARD FUNDS, INC.037,465 00Against
John Hancock17628,922 00Against
Nationwide27,9300 00For
Tema ETF Trust15,4280 00For
PRINCIPAL VARIABLE CONTRACTS FUNDS INC010,567 00Against
OLD WESTBURY FUNDS INC09,366 00Against
Goldman Sachs07,524 00Against
Blackstone Alternative Investment Funds06,500 00Against
ETF Series Solutions04,770 00Against
State Street4,2140 00For
Guardian Variable Products Trust3,8030 00For
ALPS ETF Trust03,590 00Against
AuguStar00 2,5250Abstain
Equitable01,808 00Against

Fund voting reports, all 30 managers: 13,901,933 for, 1,988,638 against, 2,525 abstained. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 93 asset managers voting on “To approve, on advisory basis, the compensation of the Company's named executive officers, as disclosed in the” at IMMUNOCORE HOLDINGS PLC, 2024-2025
Asset managerForAgainst AbstainWithheldVote
T. Rowe Price5,897,8651,803,987 00Mixed
Wellington5,492,6860 00For
Fidelity4,836,2980 00For
PRIMECAP MANAGEMENT CO/CA/2,650,4800 00For
BAKER BROS. ADVISORS LP2,322,6560 00For
RTW INVESTMENTS, LP2,117,5430 00For
Deep Track Capital, LP1,290,4530 00For
Fiera Capital Corp0742,348 00Against
ARMISTICE CAPITAL, LLC566,1250 00For
MASSACHUSETTS FINANCIAL SERVICES CO /MA/454,7430 00For
Frazier Life Sciences Management, L.P.384,7820 00For
Point720380,571 00Against
Woodline Partners LP326,9920 00For
Two Sigma0297,748 00Against
PRINCIPAL GLOBAL INVESTORS0278,580 00Against
BNP Paribas Asset Management Holding S.A.0161,292 00Against
Hudson Bay Capital Management LP0143,958 00Against
Candriam S.C.A.0134,779 00Against
AXA INVESTMENT MANAGERS UK Ltd094,762 00Against
Citadel80,5850 00For
ENVESTNET ASSET MANAGEMENT INC60,3510 00For
Allianz060,100 00Against
Renaissance058,179 00Against
BANK OF AMERICA NA51,6950 00For
Orion Porfolio Solutions, LLC044,589 00Against

Institutional-manager reports, all 93 managers: 26,605,998 for, 4,415,218 against. Showing the 25 largest; every one is in the interactive database (link above).

To approve the directors' remuneration policy, which is set forth on pages A-5 to A-15 of Annex A to the proxy…

Combines 2 wordings of this item as funds reported it.

84% Fund and manager reports combined; may count the same shares twice · no official result

FORAGAINST
Details: description as filed, votes by 31 asset managers

Description as filed by funds: To approve the directors' remuneration policy, which is set forth on pages A-5 to A-15 of Annex A to the proxy statement, which will take effect immediately after the end of the AGM.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports: 30 asset managers voting on “To approve the directors' remuneration policy, which is set forth on pages A-5 to A-15 of Annex A to the proxy” at IMMUNOCORE HOLDINGS PLC, 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard6,114,5940 00For
T. Rowe Price3,188,2311,502,755 00Mixed
Fidelity3,178,32535,520 00For
PRIMECAP Odyssey Funds748,4300 00For
MFS402,4000 00For
Principal0201,762 00Against
New York Life093,273 00Against
Pacific Life80,7950 00For
Northwestern Mutual68,5590 00For
Hartford68,2210 00For
BlackRock41,2710 00For
STEWARD FUNDS, INC.037,465 00Against
John Hancock17628,922 00Against
Nationwide27,9300 00For
Tema ETF Trust15,4280 00For
PRINCIPAL VARIABLE CONTRACTS FUNDS INC010,567 00Against
OLD WESTBURY FUNDS INC09,366 00Against
Goldman Sachs07,524 00Against
Blackstone Alternative Investment Funds06,500 00Against
ETF Series Solutions04,770 00Against
State Street4,2140 00For
Guardian Variable Products Trust3,8030 00For
ALPS ETF Trust03,590 00Against
AuguStar00 2,5250Abstain
Equitable01,808 00Against

Fund voting reports, all 30 managers: 13,943,204 for, 1,947,367 against, 2,525 abstained. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 2 asset managers voting on “To approve the directors' remuneration policy, which is set forth on pages A-5 to A-15 of Annex A to the proxy” at IMMUNOCORE HOLDINGS PLC, 2024-2025
Asset managerForAgainst AbstainWithheldVote
Fiera Capital Corp0742,348 00Against
BlackRock19,207174 00For

Institutional-manager reports, all 2 managers: 19,207 for, 742,522 against.

To approve the directors' remuneration report FOR the year ended 31 December 2024, which is set FORth as Annex A to the…

No official matchCOMPENSATION

Combines 2 wordings of this item as funds reported it.

80% of fund votes cast · no official result

FORAGAINST
Details: description as filed, votes by 27 asset managers

Description as filed by funds: To approve the directors' remuneration report FOR the year ended 31 December 2024, which is set FORth as Annex A to the proxy statement (excluding the directors' remuneration policy set out on pages A-5 to A-15 of Annex A to the proxy statement).

The 27 asset managers below reported 7,751,042 for, 1,948,478 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 7,751,042AGAINST: 1,948,478
Largest asset managers voting on “To approve the directors' remuneration report FOR the year ended 31 December 2024, which is set FORth as Annex” at IMMUNOCORE HOLDINGS PLC, 2024-2025
Asset managerForAgainst AbstainWithheldVote
T. Rowe Price3,188,2311,502,755 00Mixed
Fidelity3,178,32535,520 00For
PRIMECAP Odyssey Funds748,4300 00For
MFS402,4000 00For
Principal0201,762 00Against
New York Life093,273 00Against
Pacific Life80,7950 00For
Northwestern Mutual68,5590 00For
BlackRock60,478174 00For
STEWARD FUNDS, INC.037,465 00Against
John Hancock17628,922 00Against
Tema ETF Trust15,4280 00For
PRINCIPAL VARIABLE CONTRACTS FUNDS INC010,567 00Against
OLD WESTBURY FUNDS INC09,366 00Against
Goldman Sachs07,524 00Against
Blackstone Alternative Investment Funds06,500 00Against
ETF Series Solutions04,770 00Against
State Street4,2140 00For
Guardian Variable Products Trust3,8030 00For
ALPS ETF Trust03,590 00Against
Equitable01,808 00Against
AIG/SunAmerica01,800 00Against
ProShares01,712 00Against
Vident Advisory, LLC0937 00Against
MassMutual1030 00For

Showing the 25 largest of 27 asset managers. All 27 are in the interactive database (link above).

To authorize the audit committee to determine the U.K. statutory auditors' remuneration for the year ending December…

Calculated outcomeAUDIT-RELATEDPassed (calculated)

Combines 2 wordings of this item as funds reported it.

99.9% Majority: yes · of votes cast

FOR 99.9%
FOR: 32,741,579AGAINST: 2,105
Details: description as filed, official tally, votes by 30 asset managers

Description as filed by funds: To authorize the audit committee to determine the U.K. statutory auditors' remuneration for the year ending 31 December 2025.

IMMUNOCORE HOLDINGS PLC’s own tally for this item (“Resolution 7 : To authorize the audit committee to determine the U.K. statutory auditors' remuneration for the year ending December 31, 2025.”): 32,741,579 for, 2,105 against, per its Form 8-K filed May 15, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 30 asset managers below reported 15,890,571 for, 2,525 abstained.

FOR
FOR: 15,890,571ABSTAIN: 2,525
Largest asset managers voting on “To authorize the audit committee to determine the U.K. statutory auditors' remuneration for the year ending 31” at IMMUNOCORE HOLDINGS PLC, 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard6,114,5940 00For
T. Rowe Price4,690,9860 00For
Fidelity3,213,8450 00For
PRIMECAP Odyssey Funds748,4300 00For
MFS402,4000 00For
Principal201,7620 00For
New York Life93,2730 00For
Pacific Life80,7950 00For
Northwestern Mutual68,5590 00For
Hartford68,2210 00For
BlackRock41,2710 00For
STEWARD FUNDS, INC.37,4650 00For
John Hancock29,0980 00For
Nationwide27,9300 00For
Tema ETF Trust15,4280 00For
PRINCIPAL VARIABLE CONTRACTS FUNDS INC10,5670 00For
OLD WESTBURY FUNDS INC9,3660 00For
Goldman Sachs7,5240 00For
Blackstone Alternative Investment Funds6,5000 00For
ETF Series Solutions4,7700 00For
State Street4,2140 00For
Guardian Variable Products Trust3,8030 00For
ALPS ETF Trust3,5900 00For
AuguStar00 2,5250Abstain
Equitable1,8080 00For

Showing the 25 largest of 30 asset managers. All 30 are in the interactive database (link above).

To ratify the appointment of Deloitte LLP, a limited liability partnership organized under the laws of England, as the…

Calculated outcomeAUDIT-RELATEDPassed (calculated)

Combines 2 wordings of this item as funds reported it.

99.9% Majority: yes · of votes cast

FOR 99.9%
FOR: 32,742,156AGAINST: 1,528
Details: description as filed, official tally, votes by 30 asset managers

Description as filed by funds: To ratify the appointment of Deloitte LLP, a limited liability partnership organized under the laws of England, as our U.S. independent registered public accounting firm for the year ending 31 December 2025.

IMMUNOCORE HOLDINGS PLC’s own tally for this item (“Resolution 5: To ratify the appointment of Deloitte LLP, a limited liability partnership organized under the laws of England, as the Company's U.S. independent registered public accounting firm for the year ending Decemb”): 32,742,156 for, 1,528 against, per its Form 8-K filed May 15, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 30 asset managers below reported 15,890,571 for, 2,525 abstained.

FOR
FOR: 15,890,571ABSTAIN: 2,525
Largest asset managers voting on “To ratify the appointment of Deloitte LLP, a limited liability partnership organized under the laws of England” at IMMUNOCORE HOLDINGS PLC, 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard6,114,5940 00For
T. Rowe Price4,690,9860 00For
Fidelity3,213,8450 00For
PRIMECAP Odyssey Funds748,4300 00For
MFS402,4000 00For
Principal201,7620 00For
New York Life93,2730 00For
Pacific Life80,7950 00For
Northwestern Mutual68,5590 00For
Hartford68,2210 00For
BlackRock41,2710 00For
STEWARD FUNDS, INC.37,4650 00For
John Hancock29,0980 00For
Nationwide27,9300 00For
Tema ETF Trust15,4280 00For
PRINCIPAL VARIABLE CONTRACTS FUNDS INC10,5670 00For
OLD WESTBURY FUNDS INC9,3660 00For
Goldman Sachs7,5240 00For
Blackstone Alternative Investment Funds6,5000 00For
ETF Series Solutions4,7700 00For
State Street4,2140 00For
Guardian Variable Products Trust3,8030 00For
ALPS ETF Trust3,5900 00For
AuguStar00 2,5250Abstain
Equitable1,8080 00For

Showing the 25 largest of 30 asset managers. All 30 are in the interactive database (link above).

To re-appoint Deloitte LLP, a limited liability partnership organized under the laws of England, as the Company's U.K…

Calculated outcomeAUDIT-RELATEDPassed (calculated)

99.9% Majority: yes · of votes cast

FOR 99.9%
FOR: 32,742,175AGAINST: 1,499
Details: description as filed, official tally, votes by 30 asset managers

Description as filed by funds: To re-appoint Deloitte LLP, a limited liability partnership organized under the laws of England, as our U.K. statutory auditors, to hold office until the conclusion of our next annual general meeting of shareholders.

IMMUNOCORE HOLDINGS PLC’s own tally for this item (“Resolution 6 : To re-appoint Deloitte LLP, a limited liability partnership organized under the laws of England, as the Company's U.K. statutory auditors, to hold office until the conclusion of the next annual general mee”): 32,742,175 for, 1,499 against, per its Form 8-K filed May 15, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 30 asset managers below reported 15,890,571 for, 2,525 abstained.

FOR
FOR: 15,890,571ABSTAIN: 2,525
Largest asset managers voting on “To re-appoint Deloitte LLP, a limited liability partnership organized under the laws of England, as our U.K. s” at IMMUNOCORE HOLDINGS PLC, 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard6,114,5940 00For
T. Rowe Price4,690,9860 00For
Fidelity3,213,8450 00For
PRIMECAP Odyssey Funds748,4300 00For
MFS402,4000 00For
Principal201,7620 00For
New York Life93,2730 00For
Pacific Life80,7950 00For
Northwestern Mutual68,5590 00For
Hartford68,2210 00For
BlackRock41,2710 00For
STEWARD FUNDS, INC.37,4650 00For
John Hancock29,0980 00For
Nationwide27,9300 00For
Tema ETF Trust15,4280 00For
PRINCIPAL VARIABLE CONTRACTS FUNDS INC10,5670 00For
OLD WESTBURY FUNDS INC9,3660 00For
Goldman Sachs7,5240 00For
Blackstone Alternative Investment Funds6,5000 00For
ETF Series Solutions4,7700 00For
State Street4,2140 00For
Guardian Variable Products Trust3,8030 00For
ALPS ETF Trust3,5900 00For
AuguStar00 2,5250Abstain
Equitable1,8080 00For

Showing the 25 largest of 30 asset managers. All 30 are in the interactive database (link above).

Largest IMMUNOCORE HOLDINGS PLC shareholders voting in 2024-2025

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 50,233,609 shares outstanding at the time of that meeting.

Fund voting reports: top IMMUNOCORE HOLDINGS PLC shareholders by shares voted on “To approve, on advisory basis, the compensation of the Company's named executive officers, as…”, 2024-2025
#Asset manager % of shares outstanding
1Vanguard 12.17%
2T. Rowe Price 9.34%
3Fidelity 6.40%
4PRIMECAP Odyssey Funds 1.49%
5MFS 0.80%
6Principal 0.40%
7New York Life 0.19%
8Pacific Life 0.16%
9Northwestern Mutual 0.14%
10Hartford 0.14%
Institutional-manager reports: top IMMUNOCORE HOLDINGS PLC shareholders by shares voted on “To approve, on advisory basis, the compensation of the Company's named executive officers, as…”, 2024-2025
#Asset manager % of shares outstanding
1T. Rowe Price 15.33%
2Wellington 10.93%
3Fidelity 9.63%
4PRIMECAP MANAGEMENT CO/CA/ 5.28%
5BAKER BROS. ADVISORS LP 4.62%
6RTW INVESTMENTS, LP 4.22%
7Deep Track Capital, LP 2.57%
8Fiera Capital Corp 1.48%
9ARMISTICE CAPITAL, LLC 1.13%
10MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 0.91%

Reported IMMUNOCORE HOLDINGS PLC holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.

IMMUNOCORE HOLDINGS PLC holdings and ownership disclosed for the 2024-2025 proxy season, with each row’s source and date
HolderShares % outstandingSource, as of
Wellington Management6,131,720 12.21%Form 13F, quarter ended March 31, 2025
Entities affiliated with RTW4,869,798 9.69%Proxy statement (DEF 14A), proxy filed April 4, 2025
FMR (Fidelity)4,840,496 9.64%Form 13F, quarter ended March 31, 2025
Bahija Jallal, Ph.D.4,554,802 9.07%Proxy statement (DEF 14A), proxy filed April 4, 2025
Jallal Bahija4,493,139 8.94%Schedule 13G, filed February 14, 2025
Entities affiliated with FMR LLC4,386,070 8.73%Proxy statement (DEF 14A), proxy filed April 4, 2025
PRIMECAP MANAGEMENT CO/CA/3,772,234 7.51%Schedule 13G, filed August 14, 2025
Bellevue Group AG2,796,803 5.57%Schedule 13G, filed November 14, 2025
Vestal Point Capital, LP2,766,868 5.51%Schedule 13G, filed May 15, 2026
TANG CAPITAL MANAGEMENT, LLC2,605,608 5.19%Schedule 13G, filed October 24, 2025

Percentages above are of 50,233,609 shares outstanding, as reported by IMMUNOCORE HOLDINGS PLC on its Form 10-Q dated April 30, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this meeting

At IMMUNOCORE HOLDINGS PLC's shareholder meeting held May 15, 2025, in the 2024-2025 proxy season, 118 asset managers reported votes on at least one item in their SEC Form N-PX filings, covering 974 separate fund positions. Their filings are grouped here into 13 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — To approve, on advisory basis, the compensation of the Company's named executive officers, as… — FOR was 85% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: IMMUNOCORE HOLDINGS PLC's Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 15, 2025.

Related

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from IMMUNOCORE HOLDINGS PLC’s 10-Q dated April 30, 2025. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.

IMMUNOCORE HOLDINGS PLC proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.

Cite this page

Proxy Votes Now, “IMMUNOCORE HOLDINGS (IMCR) 2025 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/immunocore-holdings-plc/2025 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.